|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO
Nominal 
533.000 +9.500 (+1.815%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 978,340 | 2.935% | 2,057,920 | 1,933,045 | 1,540,493 | 803,933 |
| Cost of Sales | (241,437) | -16.877% | (579,139) | (659,388) | (781,308) | (276,828) |
| Gross Profit | 736,903 | 11.654% | 1,478,781 | 1,273,657 | 759,185 | 527,105 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 247,955 | -- | (355,780) | (142,545) | (467,692) | (567,364) | |
| Taxation | 140,052 | 361.001% | (26,191) | (124,221) | (106,442) | (48,735) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 388,007 | -- | (381,971) | (266,766) | (574,134) | (616,099) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (17,517) | 80.961% | (57,377) | (30,381) | 39,123 | 147,397 |
| Depreciation & Amortisation | -- | -- | 100,396 | 91,386 | 75,076 | 67,364 |
| Directors' Emoluments | -- | -- | 36,286 | 32,162 | 22,574 | 7,942 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 166.390 | -- | -166.000 | -120.000 | -284.000 | -574.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.782) | (1.939) | 0.324 | (2.836) |
| NBV per share ($) | 22.887 | -- | 20.872 | 14.558 | 10.627 | -- |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 388,007 |
| %Change | -- |
| EPS / (LPS) | RMB 1.664 |
| NBV Per Share (¥) | RMB 22.887 |